Provided by Tiger Trade Technology Pte. Ltd.

Atai Beckley Inc

4.39
-0.0600-1.35%
Post-market: 4.38-0.0102-0.23%16:24 EST
Volume:1.90M
Turnover:8.44M
Market Cap:1.59B
PE:-6.38
High:4.54
Open:4.44
Low:4.37
Close:4.45
52wk High:6.75
52wk Low:1.15
Shares:363.19M
Float Shares:309.00M
Volume Ratio:0.54
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6879
EPS(LYR):-0.9320
ROE:-100.78%
ROA:-29.25%
PB:9.98
PE(LYR):-4.71

Loading ...

Berenberg Upgrades ATAI Life Sciences to Buy From Positive, Price Target is $12

MT Newswires Live
·
Oct 24

The End Of October Often Rewards Stock Investors With This Profitable Trade

Dow Jones
·
Oct 24

Atai Life Sciences moved to Buy rating at Berenberg

TIPRANKS
·
Oct 24

A Look at Atai Life Sciences (ATAI) Valuation Following Breakthrough Therapy FDA Nod and $149.5M Capital Raise

Simply Wall St.
·
Oct 23

ATAI Life Sciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Oct 22

ATAI Life Sciences Closes $149.5 Million Public Offering

TIPRANKS
·
Oct 21

Atai Life Sciences Raises $149.5 Million From Public Offering

MT Newswires Live
·
Oct 21

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares

GlobeNewswire
·
Oct 21

DE, RKLB, NTRA, QSI: Cathie Wood Loads Up on Deere and ATAI, Trims Stakes in Rocket Lab and Biotech Stocks

TIPRANKS
·
Oct 18

Atai Life Sciences price target raised to $10 from $7 at Jefferies

TIPRANKS
·
Oct 18

Atai Life Sciences 23.725M share Spot Secondary priced at $5.48

TIPRANKS
·
Oct 17

Atai Life Sciences NV Prices Offering Of 23.7 Million Shares At $5.48 Per Share

Reuters
·
Oct 17

ATAI Life Sciences’ BPL-003 Receives FDA Breakthrough Designation

TIPRANKS
·
Oct 17

Atai Life Sciences announces common shares offering, no amount given

TIPRANKS
·
Oct 17

Press Release: atai Life Sciences Announces Proposed Public Offering of Common Shares

Dow Jones
·
Oct 17

ATAI Life Sciences and Beckley Psytech Receive FDA Breakthrough Therapy Designation for BPL-003 Nasal Spray in Treatment-Resistant Depression

Reuters
·
Oct 17

'Sell' signs are showing up in the stock market - but this number matters most

Dow Jones
·
Oct 17

Positive BPL-003 Phase 2b Results Could Be a Game Changer for Atai Life Sciences (ATAI)

Simply Wall St.
·
Oct 14

Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside

Benzinga
·
Oct 14

Needham Initiates ATAI Life Sciences N.V at Buy With $12 Price Target

MT Newswires Live
·
Oct 13